Clinical Trials Logo

Clinical Trial Summary

To observe and evaluate the safety and effectiveness of herombopag in the treatment of thrombocytopenia-related diseases in Henan Province


Clinical Trial Description

This study is designed as a real-world study on the treatment of thrombocytopenia-related diseases with Herombopag, to observe and analyze the safety and efficacy of Herombopag for thrombocytopenia-related diseases in the real world. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05130424
Study type Observational
Source Henan Cancer Hospital
Contact suxia luo
Phone 18638553211
Email luosxrm@163.com
Status Recruiting
Phase
Start date September 29, 2021
Completion date September 2023